We have located links that may give you full text access.
JOURNAL ARTICLE
META-ANALYSIS
Application of enhanced recovery after gastric cancer surgery: An updated meta-analysis.
World Journal of Gastroenterology : WJG 2018 April 15
AIM: To provide an updated assessment of the safety and efficacy of enhanced recovery after surgery (ERAS) protocols in elective gastric cancer (GC) surgery.
METHODS: PubMed, Medline, EMBASE, World Health Organization International Trial Register, and Cochrane Library were searched up to June 2017 for all available randomized controlled trials (RCTs) comparing ERAS protocols and standard care (SC) in GC surgery. Thirteen RCTs, with a total of 1092 participants, were analyzed in this study, of whom 545 underwent ERAS protocols and 547 received SC treatment.
RESULTS: No significant difference was observed between ERAS and control groups regarding total complications ( P = 0.88), mortality ( P = 0.50) and reoperation ( P = 0.49). The incidence of pulmonary infection was significantly reduced ( P = 0.03) following gastrectomy. However, the readmission rate after GC surgery nearly tripled under ERAS ( P = 0.009). ERAS protocols significantly decreased the length of postoperative hospital stay ( P < 0.00001) and medical costs ( P < 0.00001), and accelerated bowel function recovery, as measured by earlier time to the first flatus ( P = 0.0004) and the first defecation ( P < 0.0001). Moreover, ERAS protocols were associated with a lower level of serum inflammatory response, higher serum albumin, and superior short-term quality of life (QOL).
CONCLUSION: Collectively, ERAS results in accelerated convalescence, reduction of surgical stress and medical costs, improved nutritional status, and better QOL for GC patients. However, high-quality multicenter RCTs with large samples and long-term follow-up are needed to more precisely evaluate ERAS in radical gastrectomy.
METHODS: PubMed, Medline, EMBASE, World Health Organization International Trial Register, and Cochrane Library were searched up to June 2017 for all available randomized controlled trials (RCTs) comparing ERAS protocols and standard care (SC) in GC surgery. Thirteen RCTs, with a total of 1092 participants, were analyzed in this study, of whom 545 underwent ERAS protocols and 547 received SC treatment.
RESULTS: No significant difference was observed between ERAS and control groups regarding total complications ( P = 0.88), mortality ( P = 0.50) and reoperation ( P = 0.49). The incidence of pulmonary infection was significantly reduced ( P = 0.03) following gastrectomy. However, the readmission rate after GC surgery nearly tripled under ERAS ( P = 0.009). ERAS protocols significantly decreased the length of postoperative hospital stay ( P < 0.00001) and medical costs ( P < 0.00001), and accelerated bowel function recovery, as measured by earlier time to the first flatus ( P = 0.0004) and the first defecation ( P < 0.0001). Moreover, ERAS protocols were associated with a lower level of serum inflammatory response, higher serum albumin, and superior short-term quality of life (QOL).
CONCLUSION: Collectively, ERAS results in accelerated convalescence, reduction of surgical stress and medical costs, improved nutritional status, and better QOL for GC patients. However, high-quality multicenter RCTs with large samples and long-term follow-up are needed to more precisely evaluate ERAS in radical gastrectomy.
Full text links
Trending Papers
Acute and non-acute decompensation of liver cirrhosis (47/130).Liver International : Official Journal of the International Association for the Study of the Liver 2024 March 2
Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM).Clinical Infectious Diseases 2024 March 6
Status epilepticus: what's new for the intensivist.Current Opinion in Critical Care 2024 Februrary 15
Administration of methylene blue in septic shock: pros and cons.Critical Care : the Official Journal of the Critical Care Forum 2024 Februrary 17
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app